ICU Medical and Savers report Q3 2026 revenue growth with operational improvements

ICU Medical reported total GAAP revenue of $560.4 million for the third quarter of 2026, representing a 4% increase compared to the prior year, according to an earnings call transcript on aol.com. The company's non-GAAP organic revenue growth was 5%, supported by strong performance in core differentiated businesses and stable demand environments.

Adjusted EBITDA for ICU Medical rose 8% year over year to $113.9 million, while adjusted diluted earnings per share increased to $2.44 from $2.03. The adjusted gross margin improved by one percentage point to 42%, attributed to integration synergies and a favorable product mix. Consumables revenue set a record at $298.4 million, growing 5%, and infusion systems revenue increased 11%, driven by strong sales of large volume pumps.

Savers also reported positive results for Q3 2026, with net sales reaching $463.1 million, an 8.5% increase driven by new store performance and comparable store growth, as stated in their earnings call transcript on aol.com. U.S. net sales increased 12.2%, reflecting broad-based growth across regions and customer demographics, while Canadian net sales rose 2.5% or 4.3% on a constant-currency basis due to productivity initiatives that expanded margins.

Adjusted EBITDA for Savers grew 8% year over year to $75.9 million, resulting in an adjusted EBITDA margin of 16.4%. The company improved from a GAAP net loss of $14.0 million in the prior-year period to a GAAP net income of $23.4 million, or $0.15 per diluted share. Adjusted net income, excluding costs related to debt extinguishment and transaction expenses, was $25.5 million, or $0.16 per diluted share.

These results indicate operational improvements and revenue growth for both companies in the third quarter of 2026. Investors and industry watchers will likely monitor how these companies continue to manage growth, costs, and market challenges in upcoming quarters.